Obese individuals used lower insulin doses than lean ones, suggesting either suboptimal insulin treatment or clinical heterogeneity of type 1 diabetes, in which higher weight is possibly associated to higher residual beta-cell function. This evidence concerns the gene INS and type 1 diabetes mellitus.